Clinical Trials Directory

Trials / Completed

CompletedNCT06642467

BGEM Use as Blood Glucose Prediction Model in T2DM Population of Indonesia

Status
Completed
Phase
Study type
Observational
Enrollment
885 (actual)
Sponsor
Krida Wacana Christian University · Academic / Other
Sex
All
Age
18 Years – 59 Years
Healthy volunteers
Not accepted

Summary

Using signals from consumer-grade PPG sensors on wrist wearables, smart rings or hearables, BGEM® AI model computes the relevant digital biomarkers correlated with the change of blood glucose level to predict a blood glucose result for monitoring and evaluating diabetic risks Ukrida in collaboration with Actxa \& Lif aims to enhance the current model's prediction accuracy to predict the blood glucose levels of individuals almost as accurately as a glucometer. To achieve this, Actxa aims to collect data from around 500 individuals with diabetes in this exercise and 400 healthy or undiagnosed (prediabetes/diabetes) individuals.

Detailed description

Background Powered by our AI-driven algorithm, the Actxa's Blood Glucose Evaluation and Monitoring (BGEM®) is a cloud-based technology that enables wearables with photoplethysmography (PPG) sensors to monitor and evaluate diabetic risk of individuals regularly in a non-invasive way. Using signals from consumer-grade PPG sensors on wrist wearables, smart rings or hearables, BGEM® AI model computes the relevant digital biomarkers correlated with the change of blood glucose level to predict a blood glucose result for monitoring and evaluating diabetic risks. Our previous study has shown the potential of using PPG sensors to detect elevated blood glucose levels among a non-diabetic population1. Objective Ukrida in collaboration with Actxa \& Lif to enhance the current model's prediction accuracy to predict the blood glucose levels of individuals almost as accurately as a glucometer. To achieve this, Actxa aims to collect data from around 500 individuals with diabetes in this exercise and 400 healthy or undiagnosed (prediabetes/diabetes) individuals, as part of Actxa's collaboration with UKRIDA Hospital. With the data collected, our algorithm holds the potential to significantly improve the management of blood glucose levels for people with and without diabetes, ultimately enhancing their overall quality of life.

Conditions

Interventions

TypeNameDescription
DEVICEBGEMBGEM is an ai driven model to predict blood glucose using ppg sensor

Timeline

Start date
2024-07-30
Primary completion
2024-10-05
Completion
2024-10-05
First posted
2024-10-15
Last updated
2024-10-15

Locations

1 site across 1 country: Indonesia

Source: ClinicalTrials.gov record NCT06642467. Inclusion in this directory is not an endorsement.